Media hub

Centenary Institute researchers have uncovered new genetic causes of inherited heart conditions, providing families with vital answers to guide treatment and prevention.

A new study by the Centenary Institute and the Sydney Local Health District has found that a specialised blood test can detect alcohol use in people with liver disease far more accurately than commonly used biomarker tests or patient self-reports. The breakthrough could help clinicians make better treatment decisions and guide eligibility for liver transplants.

A new study led by the Centenary Institute and the University of Sydney shows that a nasal vaccine could offer powerful protection against COVID-19. It works by stopping infection in the nose before the virus spreads through the body.

A breathtaking collection of images capturing the wonder and complexity of medical science has been unveiled through the Centenary Institute’s 2025 When Art Meets Science image prize competition.

The Centenary Institute and Cure The Future Foundation have announced a new philanthropic partnership to accelerate research into life-changing treatments for rare genetic diseases and cancers.

A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney has shown strong potential to protect against both current and emerging coronavirus variants. By targeting features shared by a range of coronaviruses, the vaccine is designed to offer broader and longer-lasting protection as the virus continues to evolve.

Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies for a range of serious genetic disorders including Duchenne muscular dystrophy, Pompe disease and haemophilia.

Researchers from the Centenary Institute have uncovered a reason why some people with haemophilia A develop resistance to their critical treatment, paving the way for the development of more effective therapies.

Researchers from the Centenary Institute, in collaboration with the University of Sydney, have developed a powerful new tool to evolve proteins directly within mammalian cells, offering a more effective way to design medical treatments tailored to the human body.

New research from the Centenary Institute has found that switching off a specific protein in liver cells may help prevent the early development of liver cancer.

Each week in Australia, up to three young people die suddenly and unexpectedly from sudden cardiac death, often due to an undiagnosed genetic heart condition. These conditions typically go unnoticed until tragedy strikes, leaving families devastated and searching for answers.

A team led by Dr Chuck Bailey at the Centenary Institute has been awarded a National Health and Medical Research Council (NHMRC) Ideas Grant to develop safer and more effective gene therapies.